No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]

por Newsome, Scott D., Binns, Cherie, Kaunzner, Ulrike W., Morgan, Seth, Halper, June
Publicado 2023

Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195

por Kang, Yeona, Schlyer, David, Kaunzner, Ulrike W., Kuceyeski, Amy, Kothari, Paresh J., Gauthier, Susan A.
Publicado 2018

A study of patients with aggressive multiple sclerosis at disease onset

por Kaunzner, Ulrike W, Kumar, Gaurav, Askin, Gulce, Gauthier, Susan A, Nealon, Nancy N, Vartanian, Timothy, Perumal, Jai S
Publicado 2016

Brachial plexopathy as a complication of COVID-19

por Han, Catherine Young, Tarr, Andrew M, Gewirtz, Alexandra N, Kaunzner, Ulrike W, Roy-Burman, Paula, Cutler, Todd S, MacGowan, Daniel JL
Publicado 2021

Black African and Latino/a identity correlates with increased plasmablasts in MS

por Telesford, Kiel M., Kaunzner, Ulrike W., Perumal, Jai, Gauthier, Susan A., Wu, Xian, Diaz, Ivan, Kruse-Hoyer, Mason, Engel, Casey, Marcille, Melanie, Vartanian, Timothy
Publicado 2019

Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis

por Marcille, Melanie, Hurtado Rúa, Sandra, Tyshkov, Charles, Jaywant, Abhishek, Comunale, Joseph, Kaunzner, Ulrike W., Nealon, Nancy, Perumal, Jai S., Zexter, Lily, Zinger, Nicole, Bruvik, Olivia, Wang, Yi, Sweeney, Elizabeth, Kuceyeski, Amy, Nguyen, Thanh D., Gauthier, Susan A.
Publicado 2022

QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions

por Gillen, Kelly M., Mubarak, Mayyan, Park, Calvin, Ponath, Gerald, Zhang, Shun, Dimov, Alexey, Levine‐Ritterman, Maya, Toro, Steven, Huang, Weiyuan, Amici, Stephanie, Kaunzner, Ulrike W., Gauthier, Susan A., Guerau‐de‐Arellano, Mireia, Wang, Yi, Nguyen, Thanh D., Pitt, David
Publicado 2021

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

por Shinoda, Koji, Li, Rui, Rezk, Ayman, Mexhitaj, Ina, Patterson, Kristina R., Kakara, Mihir, Zuroff, Leah, Bennett, Jeffrey L., von Büdingen, H.-Christian, Carruthers, Robert, Edwards, Keith R., Fallis, Robert, Giacomini, Paul S., Greenberg, Benjamin M., Hafler, David A., Ionete, Carolina, Kaunzner, Ulrike W., Lock, Christopher B., Longbrake, Erin E., Pardo, Gabriel, Piehl, Fredrik, Weber, Martin S., Ziemssen, Tjalf, Jacobs, Dina, Gelfand, Jeffrey M., Cross, Anne H., Cameron, Briana, Musch, Bruno, Winger, Ryan C., Jia, Xiaoming, Harp, Christopher T., Herman, Ann, Bar-Or, Amit
Publicado 2023